{"entity":{"type":"insider","cik":"0001470981","url":"/insider/0001470981","json_url":"/insider/0001470981.json","name":"Ji Henry","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":42,"n_filings":26,"first":"2012-05-16","last":"2024-10-31","span_basis":"filed_date"},"name_variants":[{"name":"Ji Henry","source":"filing","n_filings":26,"first_seen":"2012-05-16","last_seen":"2024-10-31"}],"transactions":[{"id":2680520,"accession":"0000950170-24-119394","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-119394","line_url":"/filing/0000950170-24-119394#line-1","is_derivative":false,"issuer_cik":"0001470981","issuer_name":"Scilex Holding Co","issuer_ticker":"SCLX","issuer_name_source":null,"issuer_url":"/issuer/0001470981","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (Executive Chairperson)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairperson","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8888.0,"shares_display":"8,888","price_per_share":0.9396,"price_display":"0.94","price_state":"stated","total_value":8351.1648,"total_display":"8,351.16","total_whole":"8,351","shares_owned_after":320161.0,"shares_owned_after_display":"320,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-31","filed_date":"2024-10-31","scope":"insider"},{"id":2680392,"accession":"0000950170-24-115449","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-115449","line_url":"/filing/0000950170-24-115449#line-1","is_derivative":false,"issuer_cik":"0001470981","issuer_name":"Scilex Holding Co","issuer_ticker":"SCLX","issuer_name_source":null,"issuer_url":"/issuer/0001470981","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (Executive Chairperson)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairperson","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":0.971,"price_display":"0.97","price_state":"stated","total_value":9710.0,"total_display":"9,710.00","total_whole":"9,710","shares_owned_after":60070.0,"shares_owned_after_display":"60,070","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-10-17","filed_date":"2024-10-18","scope":"insider"},{"id":2037305,"accession":"0000950170-24-062009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-062009","line_url":"/filing/0000950170-24-062009#line-1","is_derivative":false,"issuer_cik":"0001470981","issuer_name":"Scilex Holding Co","issuer_ticker":"SCLX","issuer_name_source":null,"issuer_url":"/issuer/0001470981","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (Executive Chairperson)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairperson","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":0.8797,"price_display":"0.88","price_state":"stated","total_value":43985.0,"total_display":"43,985.00","total_whole":"43,985","shares_owned_after":50070.0,"shares_owned_after_display":"50,070","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-05-17","filed_date":"2024-05-17","scope":"insider"},{"id":6631721,"accession":"0001209191-22-049065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-049065","line_url":"/filing/0001209191-22-049065#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":88888.0,"shares_display":"88,888","price_per_share":2.0177,"price_display":"2.02","price_state":"stated","total_value":179349.3176,"total_display":"179,349.32","total_whole":"179,349","shares_owned_after":4765805.0,"shares_owned_after_display":"4,765,805","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-07","filed_date":"2022-09-07","scope":"insider"},{"id":6212306,"accession":"0001209191-22-048811","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-048811","line_url":"/filing/0001209191-22-048811#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":55555.0,"shares_display":"55,555","price_per_share":1.9599,"price_display":"1.96","price_state":"stated","total_value":108882.2445,"total_display":"108,882.24","total_whole":"108,882","shares_owned_after":4676917.0,"shares_owned_after_display":"4,676,917","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-09-06","filed_date":"2022-09-06","scope":"insider"},{"id":6252535,"accession":"0001209191-22-047741","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-047741","line_url":"/filing/0001209191-22-047741#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":33333.0,"shares_display":"33,333","price_per_share":2.11,"price_display":"2.11","price_state":"stated","total_value":70332.63,"total_display":"70,332.63","total_whole":"70,333","shares_owned_after":2121362.0,"shares_owned_after_display":"2,121,362","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-26","filed_date":"2022-08-26","scope":"insider"},{"id":6374184,"accession":"0001209191-22-047558","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-047558","line_url":"/filing/0001209191-22-047558#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":22222.0,"shares_display":"22,222","price_per_share":2.0596,"price_display":"2.06","price_state":"stated","total_value":45768.4312,"total_display":"45,768.43","total_whole":"45,768","shares_owned_after":2088029.0,"shares_owned_after_display":"2,088,029","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-25","filed_date":"2022-08-25","scope":"insider"},{"id":6496914,"accession":"0001209191-22-036760","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-036760","line_url":"/filing/0001209191-22-036760#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.3999,"price_display":"1.40","price_state":"stated","total_value":13999.0,"total_display":"13,999.00","total_whole":"13,999","shares_owned_after":2065807.0,"shares_owned_after_display":"2,065,807","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-14","filed_date":"2022-06-14","scope":"insider"},{"id":6342740,"accession":"0000850261-18-000009","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000850261-18-000009","line_url":"/filing/0000850261-18-000009#line-2","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":64600.0,"shares_display":"64,600","price_per_share":9.95,"price_display":"9.95","price_state":"stated","total_value":642770.0,"total_display":"642,770.00","total_whole":"642,770","shares_owned_after":1906177.0,"shares_owned_after_display":"1,906,177","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-02-28","filed_date":"2018-02-28","scope":"insider"},{"id":6283837,"accession":"0001144204-18-002932","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-18-002932","line_url":"/filing/0001144204-18-002932#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1801801.0,"shares_display":"1,801,801","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":1841577.0,"shares_owned_after_display":"1,841,577","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-21","filed_date":"2018-01-22","scope":"insider"},{"id":4864929,"accession":"0001144204-17-032732","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001144204-17-032732","line_url":"/filing/0001144204-17-032732","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":29001.0,"shares_display":"29,001","price_per_share":1.8124133650563774,"price_display":"1.81","price_state":"stated","total_value":52561.8,"total_display":"52,561.80","total_whole":"52,562","shares_owned_after":20001.0,"shares_owned_after_display":"20,001","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-06-15","filed_date":"2017-06-15","scope":"insider","n_lines":2},{"id":4703005,"accession":"0001144204-17-021046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001144204-17-021046","line_url":"/filing/0001144204-17-021046#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":139776.0,"shares_owned_after_display":"139,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-04-19","filed_date":"2017-04-19","scope":"insider"},{"id":4250289,"accession":"0000899243-17-004969","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-004969","line_url":"/filing/0000899243-17-004969#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.6,"price_display":"5.60","price_state":"stated","total_value":11200.0,"total_display":"11,200.00","total_whole":"11,200","shares_owned_after":39776.0,"shares_owned_after_display":"39,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-22","filed_date":"2017-02-22","scope":"insider"},{"id":9204473,"accession":"0000899243-17-003639","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-003639","line_url":"/filing/0000899243-17-003639#line-1","is_derivative":false,"issuer_cik":"0001470981","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0001470981","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":103000.0,"total_display":"103,000.00","total_whole":"103,000","shares_owned_after":37776.0,"shares_owned_after_display":"37,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-10","filed_date":"2017-02-10","scope":"insider"},{"id":4967184,"accession":"0000899243-17-002783","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-17-002783","line_url":"/filing/0000899243-17-002783#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":5.15,"price_display":"5.15","price_state":"stated","total_value":103000.0,"total_display":"103,000.00","total_whole":"103,000","shares_owned_after":37776.0,"shares_owned_after_display":"37,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-02-03","filed_date":"2017-02-03","scope":"insider"},{"id":8934479,"accession":"0000899243-15-004075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-15-004075","line_url":"/filing/0000899243-15-004075","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"SRNE 35 March 2016 Call Options","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":0.9473,"price_display":"0.95","price_state":"stated","total_value":473.65,"total_display":"473.65","total_whole":"474","shares_owned_after":497.0,"shares_owned_after_display":"497","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-26","filed_date":"2015-08-26","scope":"insider","n_lines":2},{"id":8627770,"accession":"0000899243-15-003863","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-003863","line_url":"/filing/0000899243-15-003863#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8888.0,"shares_display":"8,888","price_per_share":12.843,"price_display":"12.84","price_state":"stated","total_value":114148.584,"total_display":"114,148.58","total_whole":"114,149","shares_owned_after":17776.0,"shares_owned_after_display":"17,776","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-24","filed_date":"2015-08-24","scope":"insider"},{"id":8233995,"accession":"0000899243-15-003740","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-15-003740","line_url":"/filing/0000899243-15-003740#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8888.0,"shares_display":"8,888","price_per_share":13.076,"price_display":"13.08","price_state":"stated","total_value":116219.488,"total_display":"116,219.49","total_whole":"116,219","shares_owned_after":14888.0,"shares_owned_after_display":"14,888","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-21","filed_date":"2015-08-21","scope":"insider"},{"id":7055460,"accession":"0001209191-14-067509","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-14-067509","line_url":"/filing/0001209191-14-067509","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5999.0,"shares_display":"5,999","price_per_share":4.825335889314886,"price_display":"4.83","price_state":"stated","total_value":28947.19,"total_display":"28,947.19","total_whole":"28,947","shares_owned_after":16999.0,"shares_owned_after_display":"16,999","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-10","filed_date":"2014-11-10","scope":"insider","n_lines":6},{"id":6355638,"accession":"0001209191-14-067218","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-14-067218","line_url":"/filing/0001209191-14-067218","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":4.5625,"price_display":"4.56","price_state":"stated","total_value":18250.0,"total_display":"18,250.00","total_whole":"18,250","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-07","filed_date":"2014-11-07","scope":"insider","n_lines":4},{"id":6297267,"accession":"0001209191-14-066980","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-14-066980","line_url":"/filing/0001209191-14-066980","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":4.533333333333333,"price_display":"4.53","price_state":"stated","total_value":13600.0,"total_display":"13,600.00","total_whole":"13,600","shares_owned_after":6000.0,"shares_owned_after_display":"6,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-06","filed_date":"2014-11-06","scope":"insider","n_lines":2},{"id":4231227,"accession":"0001209191-13-055480","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-055480","line_url":"/filing/0001209191-13-055480","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.915,"price_display":"8.92","price_state":"stated","total_value":8915.0,"total_display":"8,915.00","total_whole":"8,915","shares_owned_after":1728162.0,"shares_owned_after_display":"1,728,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-05","filed_date":"2013-12-05","scope":"insider","n_lines":2},{"id":4231205,"accession":"0001209191-13-055398","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-13-055398","line_url":"/filing/0001209191-13-055398","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.53571,"price_display":"8.54","price_state":"stated","total_value":8535.71,"total_display":"8,535.71","total_whole":"8,536","shares_owned_after":1726662.0,"shares_owned_after_display":"1,726,662","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-04","filed_date":"2013-12-05","scope":"insider","n_lines":4},{"id":4739145,"accession":"0001181431-13-060310","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-060310","line_url":"/filing/0001181431-13-060310#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.466,"price_display":"8.47","price_state":"stated","total_value":8466.0,"total_display":"8,466.00","total_whole":"8,466","shares_owned_after":1726162.0,"shares_owned_after_display":"1,726,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-22","filed_date":"2013-11-22","scope":"insider"},{"id":5338975,"accession":"0001209191-13-053387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-13-053387","line_url":"/filing/0001209191-13-053387","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":8.5945,"price_display":"8.59","price_state":"stated","total_value":17189.0,"total_display":"17,189.00","total_whole":"17,189","shares_owned_after":1725162.0,"shares_owned_after_display":"1,725,162","ownership_form":"I","is_10b5_1":null,"transaction_date":"2013-11-19","filed_date":"2013-11-20","scope":"insider","n_lines":2},{"id":2502322,"accession":"0001181431-12-030393","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-12-030393","line_url":"/filing/0001181431-12-030393#line-1","is_derivative":false,"issuer_cik":"0000850261","issuer_name":"Sorrento Therapeutics, Inc.","issuer_ticker":"SRNE","issuer_name_source":null,"issuer_url":"/issuer/0000850261","owner_cik":"0001470981","owner_name":"Ji Henry","owner_display_name":"Ji Henry","owner_url":"/insider/0001470981","role":"Director, Officer (Interim CEO and CSO), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CEO and CSO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6250000.0,"shares_display":"6,250,000","price_per_share":0.16,"price_display":"0.16","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","total_whole":"1,000,000","shares_owned_after":6250000.0,"shares_owned_after_display":"6,250,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2012-05-15","filed_date":"2012-05-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":42,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":42,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":42},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001820190","name":"Scilex Holding Co","url":"/issuer/0001820190","role":"Director, Officer (Executive Chairperson)","n_filings":3,"first_seen":"2024-05-17","last_seen":"2024-10-31"},{"type":"issuer","type_label":"ISSUER","cik":"0000850261","name":"Sorrento Therapeutics, Inc.","url":"/issuer/0000850261","role":"Director, Officer, Ten percent owner","n_filings":23,"first_seen":"2012-05-16","last_seen":"2022-09-07"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001470981","retrieved_at":"2026-08-26T20:21:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}